van Eijs, Mick J. M. http://orcid.org/0000-0002-9763-6704
van der Wagen, Lotte E.
Mous, Rogier
Leguit, Roos J. http://orcid.org/0000-0001-9990-2802
van de Corput, Lisette http://orcid.org/0000-0003-4089-980X
van Lindert, Anne S. R. http://orcid.org/0000-0002-4072-2441
Suelmann, Britt B. M. http://orcid.org/0000-0002-7155-3337
Kamphuis, Anna M.
Nierkens, Stefan http://orcid.org/0000-0003-3406-817X
Suijkerbuijk, Karijn P. M. http://orcid.org/0000-0003-3604-5430
Article History
Received: 6 February 2022
Accepted: 20 May 2022
First Online: 13 June 2022
Declarations
:
: KS: advisory relationships with Bristol-Myers Squibb, Novartis, MSD, Pierre Fabre and Abbvie and honoraria from Novartis and Roche, all outside the submitted work and paid to institution. All other authors declare no conflicts of interest.